FDA campaign H-0446-2025
Class IIIHazard
Under potency / misbranding: product fails to meet labeled lithium orotate potency. (Downstream recall) from supplier of ingredient.
Distribution
Distribution includes Amazon, Excel 3PL and Encore Fulfillment. Nationwide
REKALLD area-alert coverage: nationwide (our reading of the distribution above)
The text above is quoted verbatim from the FDA record. Confirm the affected units and the remedy with the manufacturer or FDA. Recall data may be incomplete, delayed, or superseded.